Roche Products Ltd General correspondence including re a 'very unfortunate letter' which appeared in <i>Lancet</i> and a new German drug called Antergan (1944); cv of Franz Bergel, director of research, and request to Dale for a supply of a compound called 2268F (1950) 1944-1953